Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?
Johnson & Johnson (NYSE:JNJ) has officially entered the U.S. soft-tissue robotic surgery market after receiving FDA De Novo…
Johnson & Johnson’s OTTAVA Robotic Surgery System Targets Long-Term Growth
Key Points Interested in Johnson & Johnson? Here are five stocks we like better. Johnson & Johnson received…